Western diet and genetic predisposition as risk factors of colon cancer

Public PhD defence on 1st of July 2016, at 12 noon.

Biomedicum Helsinki, Lecture hall 2

Author: M.Sc. Satu Valo
Division of Genetics, Department of Biosciences, University of Helsinki
Department of Medical and Clinical Genetics, University of Helsinki

Opponent: Prof. Karl Heinimann, MD, PhD
Department of Medical Genetics, University Hospital of Basel, Switzerland

Prof. Päivi Peltomäki, Prof. Minna Nyström, M.Sc Satu Valo and Prof. Karl Heinimann

Prof. Päivi Peltomäki, Prof. Minna Nyström, M.Sc Satu Valo and Prof. Karl Heinimann

PhD defence

PhD defence

Annual National HNPCC Meeting

The Annual Meeting of the Finnish collaborative HNPCC reseach groups took place at Hämeenkylän Kartano in Vantaa on 4th of March.

In her presentation, Prof. Minna Nyström introduced DiagMMR™ a new tool for Lynch syndrome carrier diagnosis (http://www.lscancerdiag.com/). Other members of Prof. Päivi Peltomäki’s and Prof. Minna Nyström’s research groups gave presentations regarding some of the recent projects related to the Western diet effects on colon cancer predisposition (MSc. Marjaana Pussila, MSc. Satu Valo and BSc. Pauliina Paloviita) and promoter specific alterations of APC in FAP (PhD Taina Nieminen).

MSc. Satu Valo

HNPCC Taina3

PhD. Taina Nieminen

 

 

Characteristics of colorectal tumors with inactive Wnt signaling

The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription

Abdel-Rahman WM, Lotsari-Salomaa JE, Kaur S, Niskakoski A, Knuutila S, Järvinen H, Mecklin JP and Peltomäki P.

All colorectal cancer cell lines except RKO displayed active β-catenin/TCF regulated transcription. This feature of RKO was noted in familial colon cancers; hence our aim was to dissect its carcinogenic mechanism. MFISH and CGH revealed distinct instability of chromosome structure in RKO. Gene expression microarray of RKO versus 7 colon cancer lines (with active Wnt signaling) and 3 normal specimens revealed 611 differentially expressed genes. The majority of the tested gene loci were susceptible to LOH in primary tumors with various β-catenin localizations as a surrogate marker for β-catenin activation. The immunohistochemistry of selected genes (IFI16, RGS4, MCTP1, DGKI, OBCAM/OPCML, and GLIPR1) confirmed that they were differentially expressed in clinical specimens. Since epigenetic mechanisms can contribute to expression changes, selected target genes were evaluated for promoter methylation in patient specimens from sporadic and hereditary colorectal cancers. CMTM3, DGKI, and OPCML were frequently hypermethylated in both groups, whereas KLK10, EPCAM, and DLC1 displayed subgroup specificity. The overall fraction of hypermethylated genes was higher in tumors with membranous β-catenin. We identified novel genes in colorectal carcinogenesis that might be useful in personalized tumor profiling. Tumors with inactive Wnt signaling are a heterogeneous group displaying interaction of chromosomal instability, Wnt signaling, and epigenetics.

Gastroenterol Res Pract. 2016

Update on Lynch syndrome genomics

Peltomäki P.

Four main DNA mismatch repair (MMR) genes have been identified, MLH1, MSH2, MSH6, and PMS2, which when mutated cause susceptibility to Lynch syndrome (LS). LS is one of the most prevalent hereditary cancer syndromes in man and accounts for 1-3 % of unselected colorectal carcinomas and some 15 % of those with microsatellite instability and/or absent MMR protein. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) maintains a database for LS-associated mutations since 1996. The database was recently reorganized to efficiently gather published and unpublished data and to classify the variants according to a five-tiered scheme linked to clinical recommendations. This review provides an update of germline mutations causing susceptibility to LS based on information available in the InSiGHT database and the latest literature. MMR gene mutation profiles, correlations between genotype and phenotype, and possible mechanisms leading to the characteristic spectrum of tumors in LS are discussed in light of the different functions of MMR proteins, many of which directly serve cancer avoidance.

Review in Fam cancer, 2016.

Fig. Distributions of the types of germline variants across each MMR gene (Peltomäki  P, Fam Cancer 2016).

Fig. Distributions of the types of germline variants across each MMR gene (Peltomäki P, Fam Cancer 2016).

Jane and Aatos Erkko Foundation Awards 1.25 million for Hereditary Cancer Research

Prof. Päivi Peltomäki (PI) together with Prof. Minna Nyström (Co-PI) and Prof. Jukka-Pekka Mecklin (Co-PI) were nominated by Jane and Aatos Erkko Foundation to receive a grant of 1.25 million euro for their joint interdisciplinary research to recognize molecular mechanisms of hereditary cancer susceptibility in association with lifestyle and diet in aim to improve diagnosis and cancer prevention.

Announcement in Finnish:

Perinnöllinen syöpä (Lynchin oireyhtymä) syövänkehityksen ja -ehkäisyn mallina

Jane ja Aatos Erkon Säätiö on myöntänyt merkittävän (1.25 miljoonan euron) apurahan professorien Päivi Peltomäen, Minna Nyströmin ja Jukka-Pekka Mecklinin johtamalle poikkitieteelliselle hankkeelle.

Syövän synty nähdään pääsääntöisesti joko elintavoista tai synnynnäisestä alttiudesta johtuvaksi. Elintapatekijöiden vaikutusta on edelleenkin vaikea tutkimuksellisesti konkretisoida. Tuoreet tutkimuslöydöksemme kuitenkin paljastivat, että elintapatekijät kuten ravinto ja liikunta näyttävät vaikuttavan myös perinnöllisen syövän syntyyn. Tässä tutkimuksessa pyritään yhdistämään eri lähestymistapoja ja käyttämään pitkään tunnettua periytyvää suolisyöpäalttiutta syövän syntymekanismien ja ehkäisyn mallina ja vertaamaan havaintoja niihin suolisyöpiin, joiden ajatellaan syntyvän ei-periytyvästi.

Tutkimusprojekti selvittää, miksi alttius sairastua paksusuolisyöpään vaihtelee yksilöllisesti, mitkä ovat kasvaimen molekyyli- ja kudostason syntymekanismit ja miten kehittyminen syöväksi voidaan estää. Tieteellisten tavoitteiden ohella tutkimuksella on tärkeä kansanterveydellinen päämäärä: tehostaa paksusuolisyövän ehkäisyä alttiuden varhaisen tunnistamisen ja omien elintapavalintojen kautta.

Erkko2016

Epigenetic Alterations in Sporadic and Familial Cancers

Public PhD defense on 20th of November 2015, at 12 noon.

Auditorium XIV, University main building, Fabianinkatu 33, Helsinki

Author: M.Sc. Emmi Joensuu

Department of Medical and Clinical Genetics, University of Helsinki

Opponent: Prof. Anne Kallioniemi, MD, PhD

Department of Biomedical Sciences, University of Tampere

Welcome!

Prof. Anne Kallioniemi, Prof. Päivi Peltomäki and M.Sc Emmi Joensuu. Kuvaaja: Annette Gylling

Prof. Anne Kallioniemi, Prof. Päivi Peltomäki and M.Sc Emmi Joensuu. Photograph: Annette Gylling

Nobel Lecture 2015 on DNA repair

Professor Nyström has the honour of delivering the Nobel Lecture 2015 in recognition of Professor Lindahl, Modrich and Sancar and their Chemistry 2015 Nobel prize winning work “For mechanistic studies of DNA repair”.

The lecture will be held together with Professor Meri’s lecture on the Physiology or Medicine Nobel prize winners works.

The lectures will be delivered on Wednesday, October 21st, 11.00-12.00 in Biocenter 2, Lecture hall 2041.

EPIGENETIC CHARACTERISTICS OF LYNCH SYNDROME-ASSOCIATED AND SPORADIC TUMORIGENESIS

Public PhD defence on 25th of September 2015 at 12 p.m

Folkhälsan, Auritorium Arean, Topeliuksenkatu 20, Helsinki

Author: M.Sc. Johanna Lotsari

Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki

Opponent: Prof. Markus Mäkinen, Department of Pathology, University of Oulu

Welcome!

M.Sc. Johanna Lotsari-Salomaa, Prof. Päivi Peltomäki and Prof. Markus Mäkinen

M.Sc. Johanna Lotsari-Salomaa, Prof. Päivi Peltomäki and Prof. Markus Mäkinen